Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice

Virology

Volumn 227, Issue 2, 1997, Pages 353-360

  Konishi, Eiji ^a   Kurane, Ichiro ^b   Mason, Peter W ^c   Shope, Robert E ^d,e   Ennis, Francis A ^b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNIZATION; JAPANESE ENCEPHALITIS VIRUS; MOLECULAR CLONING; MOUSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL;

ANIMALIA; CANARYPOX VIRUS; JAPANESE ENCEPHALITIS VIRUS; POXVIRIDAE; VACCINIA; VACCINIA VIRUS;

EID: 0031579229     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8331     Document Type: Article

References (33)

1. Altmeyer, R., Escriou, N., Girard, M., Palmenberg, A., and van der Werf, S. (1994). Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc. Natl. Acad. Sci. USA 91, 9775-9779.
2. Andersen, M. M., and Ronne, T. (1991). Side-effects with Japanese encephalitis vaccine. Lancet 337, 1044.
3. Brandt, W. E. (1988). Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses. J. Infect. Dis. 157, 1105-1111.
4. + human cytotoxic T lymphocytes. J. Virol. 63, 5086-5091.
5. Egan, M. A., Pavlat, W. A., Tartaglia, J., Paoletti, E., Weinhold, K. J., Clements, M. L., and Siliciano, R. F. (1995). Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene. J. Infect. Dis. 171, 1623-1627.
6. Fooks, A. R., Schadeck, E., Liebert, U. G., Dowsett, A. B., Rima, B. K., Steward, M., Stephenson, J. R., and Wilkinson, G. W. (1995). High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: Induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210, 456-465.
7. Germain, R. N. (1993). Antigen processing and presentation. In "Fundamental Immunology" (W. E. Paul, Ed.), 3rd ed., pp. 629-676. Raven Press, New York.
8. Hill, A. B., Mullbacher, A., Parrish, C., Coia, G., Westaway, E. G., and Blanden, R. V. (1992). Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses. J. Gen. Virol. 73, 1115-1123.
9. Kimura-Kuroda, J., and Yasui, K. (1988). Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141, 3606-3610.
10. Konishi, E., Kurane, I., Mason, P. W., Innis, B. L., and Ennis, F. A. (1995). Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 53, 278-283.
11. Konishi, E., and Mason, P. W. (1993). Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67, 1672-1675.
12. Konishi, E., Pincus, S., Fonseca, B. A. L., Shope, R. E., Paoletti, E., and Mason, P. W. (1991). Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology 185, 401-410.
13. Konishi, E., Pincus, S., Paoletti, E., Laegreid, W. W., Shope, R. E., and Mason, P. W. (1992). A highly attenuated host-range restricted vaccinia virus strain, NYVAC, encoding the prM, E and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 190, 454-458.
14. Konishi, E., Pincus, S., Paoletti, E., Shope, R. E., and Mason, P. W. (1994). Avipox virus-vectored Japanese encephalitis virus vaccines: Use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12, 633-638.
15. Kulkarni, A. B., Collins, P. L., Bacik, I., Yewdell, J. W., Bennink, J. R., Crowe, J. E., Jr., and Murphy, B. R. (1995). Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistence induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 69, 1261-1264.
16. - cytotoxic T-cell clones: Multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65, 1823-1828.
17. - cytotoxic T-cell clones. J. Virol. 68, 3283-3288.
18. Lobigs, M., Arthur, C. E., Mullbacher, A., and Blanden, R. V. (1994). The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 202, 195-201.
19. Mason, P. W. (1989). Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Wology 169, 354-364.
20. Mason, P. W., Dalrymple, J. M., Gentry, M. K., McCown, J. M., Hoke, C. H., Burke, D. S., Fournier, M. J., and Mason, T. L. (1989). Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70, 2037-2049.
21. Mason, P. W., McAda, P. C., Dalrymple, J. M., Fournier, M. J., and Mason, T. L. (1987). Expression of Japanese encephalitis virus antigens in Escherichia coli. Virology 158, 361-372.
22. Mason, P. W., Pincus, S., Fournier, M. J., Mason, T. L., Shope, R. E., and Paoletti, E. (1991). Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180, 294-305.
23. Mathur, A., Arora, K. L., and Chaturvedi, U. C. (1983). Host defence mechanisms against Japanese encephalitis virus infection in mice. J. Gen. Virol. 64, 805-811.
24. Monath, T. P. (1986). Pathobiology of the flaviviruses. In "The Togaviridae and Flaviviridae" (S. Schlesinger and M. J. Schlesinger, Eds.), pp. 375-440. Plenum, New York/London.
25. Murali-Krishna, K., Ravi, V., and Manjunath, R. (1994). Cytotoxic T lymphocytes raised against Japanese encephalitis virus: Effector cell phenotype, target specificity and in vitro virus clearance. J. Gen. Virol. 75, 799-807.
26. Perales, M. A., Schwartz, D. H., Fabry, J. A., and Lieberman, J. (1995). A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 10, 27-35.
27. Pialoux, G., Excler, J. L., Riviere, Y., Gonzalez-Canali, G., Feuillie, V., Coulaud, P., Gluckman, J. C., Matthews, T. J., Meignier, B., and Kieny, M. P. (1995). A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). AIDS Res. Hum. Retroviruses 11, 373-381.
28. + cytotoxic T lymphocytes. J. Virol. 67, 801-806.
29. Rothman, A. L., Kurane, I., Zhang, Y. M., Lai, C. J., and Ennis, F. A. (1989). Dengue virus-specific murine T-lymphocyte proliferation: Serotype specificity and response to recombinant viral proteins. J. Virol. 63, 2486-2491.
30. Schirmbeck, R., Bohm, W., Ando, K., Chisari, F. V., and Reimann, J. (1995). Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69, 5929-5934.
31. Shope, R. E. (1980). Medical significance of togaviruses: An overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. In "The Togaviruses" (R. W. Schlesinger, Ed.), pp. 47-82. Academic Press, New York.
32. Sutler, G., Wyatt, L. S., Foley, P. L., Bennink, J. R., and Moss, B. (1994). A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12, 1032-1040.
33. Tartaglia, J., Perkus, M. E., Taylor, J., Norton, E. K., Audonnet, J., Cox, W. I., Davis, S. W., van der Hoeven, J., Meignier, B., Riviere, M., Languet, B., and Paoletti, E. (1992). NYVAC: A highly attenuated strain of vaccinia virus. Virology 188, 217-232.